|
ETS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.37740002631648E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48370000122122E-08 |
| Normal-vs-Stage2 |
1.94306999999894E-05 |
| Normal-vs-Stage3 |
7.151700E-04 |
| Normal-vs-Stage4 |
3.83290000000036E-05 |
| Stage1-vs-Stage2 |
7.277000E-01 |
| Stage1-vs-Stage3 |
3.026600E-01 |
| Stage1-vs-Stage4 |
5.102800E-01 |
| Stage2-vs-Stage3 |
5.141200E-01 |
| Stage2-vs-Stage4 |
4.616600E-01 |
| Stage3-vs-Stage4 |
1.501590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59690038969984E-11 |
| Normal-vs-AfricanAmerican |
1.575160E-04 |
| Normal-vs-Asian |
2.742000E-03 |
| Caucasian-vs-AfricanAmerican |
1.392570E-01 |
| Caucasian-vs-Asian |
8.800600E-01 |
| AfricanAmerican-vs-Asian |
3.918600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07890363310048E-11 |
| Normal-vs-Female |
5.57869999999738E-05 |
| Male-vs-Female |
4.856300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.97859999998096E-06 |
| Normal-vs-Extreme_Weight |
1.20750076604281E-11 |
| Normal-vs-Obese |
6.15429999999417E-05 |
| Normal-vs-Extreme_Obese |
3.43479999997953E-09 |
| Normal_Weight-vs-Extreme_Weight |
5.731200E-01 |
| Normal_Weight-vs-Obese |
3.193000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.138780E-01 |
| Extreme_Weight-vs-Obese |
3.954000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.305790E-01 |
| Obese-vs-Extreme_Obese |
3.622500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.427900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.06540000342082E-08 |
| Normal-vs-Age(61-80Yrs) |
3.88900001091486E-09 |
| Normal-vs-Age(81-100Yrs) |
1.99409999623867E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.424780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.760400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.340300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.604000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.161680E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.297600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67998948086279E-12 |
| Normal-VS-Type2 PRCC |
2.56059995429325E-09 |
| Normal-VS-KIRP CIMP |
6.459600E-01 |
| Normal-VS-Unclassified PRCC |
1.58820000484283E-08 |
| Type1 PRCC-VS-Type2 PRCC |
3.716800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.77440000026508E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.454800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.66470000000563E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.244800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.255300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58409968370665E-11 |
| Normal-vs-N1 |
6.395200E-03 |
| Normal-vs-N2 |
1.492440E-02 |
| N0-vs-N1 |
3.989800E-02 |
| N0-vs-N2 |
6.663200E-01 |
| N1-vs-N2 |
5.126600E-01 |
|
|
